I don't understand why they didn't test patients tumors for MUC1 expression level and enrich the trial with those having high expression, that should better respond to stimuvax, as many could have had low MUC1 expression:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.